FY2029 Earnings Estimate for AVTE Issued By Wedbush
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico expects that the company will earn ($0.74) per share for the year. The consensus estimate for Aerovate […]
